Sort
11,323 grants matching “glioblastoma”
The role of SMARCAL1 in glioma telomere maintenance.
$151,523Matthew Waitkus · Duke University · K22 · FY2023 · CA
Illuminating the functions and translational potential of CDC42BP/MRCK kinases in ovarian cancer
$151,500Angela Wandinger-Ness · University Of New Mexico Health Scis Ctr · R03 · FY2021 · TR
A Diffusion-Based MRI Method to Detect Glioma Invasion
$151,500Kathleen Marie Schmainda · Medical College Of Wisconsin · R21 · FY2008 · CA
Cath B and uPAR si RNA constructs regressed glioma growth
$151,414Jasti S Rao · University Of Illinois At Chicago · R01 · FY2010 · CA
In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection
$151,360Manuel Llano · University Of Texas El Paso · R16 · FY2023 · AI
CHARACTERIZATION OF SEXUAL DIMORPHISM IN GLIOMA METABOLISM
$151,339Joseph Edward Ippolito · Washington University · K99 · FY2017 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing
$151,313Charles M Perou · Univ Of North Carolina Chapel Hill · U24 · FY2016 · CA
Histone Modification and GBM Therapy
$151,283Joseph C Loftus · Mayo Clinic Rochester · P50 · FY2015 · CA
Cellular Proliferation is a Robust Pharmacodynamic Endpoint
$151,176Alexander M Spence · University Of Washington · P01 · FY2012 · CA
Pre-Clinical Vector Production Core
$151,030William F. Goins · Brigham And Women'S Hospital · P01 · FY2020 · CA
Cyclotron and Radiochemistry Specialized Resource
$150,904Nagichettiar Satyamurthy · University Of California Los Angeles · P50 · FY2014 · CA
The role of SMARCAL1 in glioma telomere maintenance.
$150,784Matthew Waitkus · Duke University · K22 · FY2024 · CA
P I/II Intraventricular DepoCyt (OD # 06-2348) in Glioblastoma (76,730, 11/06)
$150,612Bruce Michael Frankel · Medical University Of South Carolina · R01 · FY2009 · FD
Administrative Core
$150,536John H Sampson · Duke University · P01 · FY2018 · CA
Targeting miRNA in brain tumors.
$150,285Brigham And Women'S Hospital · R21 · FY2005 · CA
Imaging
$150,280Christopher T Whitlow · Wake Forest University Health Sciences · P01 · FY2020 · CA
Novel Reporters and Delivery Vehicles
$150,252Xandra Owens Breakefield · Massachusetts General Hospital · P50 · FY2008 · CA
Development of Glioblastoma-Targeting Endofullerenes for Imaging Brain Tumors
$150,159Chris L Kepley · Luna Innovations, Inc. · R43 · FY2008 · CA
Targeted Treatments for Invasive CNS Tumors
$149,800Marthe J. Howard · University Of Toledo Health Sci Campus · R21 · FY2010 · NS
Evaluation of In Vitro Companion Diagnostic Monoclonal Antibodies for Use in a St
$149,799Christopher Horvath · Intica Biomedical, Inc. · R41 · FY2013 · CA
Live-Cell Assays of ER and Golgi Enzyme Activities
$149,757John J Naleway · Marker Gene Technologies · R43 · FY2013 · GM
A multitargeted nanocarrier inhibitor of undruggable transcription factors for treating castration resistant prostate cancer
$149,491Steven L Armentrout · Parabon Nanolabs, Inc. · R41 · FY2022 · CA
Optimizing EGFR inhibitor-based therapies in GBM
$149,271Mayo Clinic · P50 · FY2004 · CA
A Translational Framework for Methodological Rigor to Improve Patient Centered Ou
$149,163Francesca Dominici · Harvard School Of Public Health · K18 · FY2014 · HS
Brain-Penetrating Nanoparticle Therapeutics for Invasive Brain Cancer
$149,118Graeme F Woodworth · University Of Maryland Baltimore · K08 · FY2016 · NS